A population approach to the rational use of therapeutic interventions

Clinical Therapeutics

Volumn 35, Issue 10, 2013, Pages 1634-1638

  Rawlins, Michael D ^a,b  

^a ROYAL SOCIETY OF MEDICINE   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BORTEZOMIB; DABIGATRAN; ETANERCEPT; GOLIMUMAB; IMATINIB; PEMETREXED; PLACEBO; RILUZOLE; RITUXIMAB; SUNITINIB; TRASTUZUMAB;

ADVANCED CANCER; ANKYLOSING SPONDYLITIS; BREAST CANCER; CEREBROVASCULAR ACCIDENT; CHRONIC MYELOID LEUKEMIA; CLINICAL EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; DRUG COST; FRAGILITY FRACTURE; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE SYSTEM; HIP PROSTHESIS; HUMAN; KIDNEY CANCER; MALIGNANT MESOTHELIOMA; MEDICAL DECISION MAKING; MOTOR NEURON DISEASE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; NOTE; OSTEOARTHRITIS; PRACTICE GUIDELINE; PSORIASIS; UNEMPLOYMENT;

COST-BENEFIT ANALYSIS; DELIVERY OF HEALTH CARE; DRUG COSTS; HEALTH POLICY; HUMANS; SOCIAL VALUES; THERAPEUTICS; TREATMENT OUTCOME; VALUE OF LIFE;

EID: 84885860290     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2013.08.010     Document Type: Note

References (11)

1. Glassman A., Chalkidou K. Priority-Setting in Health: Building Institutions for Smarter Public Spending 2012, Centre for Global Development, Washington, DC.
2. Rawlins M.D. De Testimonio: on the evidence for decisions about the use of therapeutic interventions. Lancet 2008, 372:2152-2161.
3. Rawlins M.D. Therapeutics, Evidence and Decision-making 2011, Hodder Arnold, London, UK.
4. Song F., Loke Y.K., Walsh T., Glenny A.-M., et al. Methodological problems in the use of indirect comparisons for evaluating healthcare interventions: survey of published systematic reviews. BMJ 2009, 338:b1147.
5. Lu G., Ades A.E. Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med 2004, 23:3105-3124.
6. Szende A., Oppe M., Devlin N. EQ-5D Value Sets: Inventory, Comparative Review and User Guide 2007, Springer, Dordrecht, The Netherlands.
7. Rawlins M.D., Culyer A.J. National Institute for Clinical Excellence and its value judgments. BMJ 2004, 329:224-227.
8. Rawlins M.D. Pharmacopolitics and deliberative democracy. Clin Med 2005, 5:471-475.
9. Beachamp T.L., Childress J.F. Principles of Biomedical Ethics 2001, Oxford University Press, New York, NY. 5th ed.
10. Rawlins M., Barnett D., Stevens A. Pharmacoeconomics: NICE's approach to decision-making. Br J Clin Pharmacol 2010, 70:346-349.
11. Rawlins M.D. NICE times: a valedictory dispatch. Lancet 2013, 381:2225-2227.